By Matt Grossman

Johnson & Johnson on Wednesday raised its guidance for adjusted earnings and for revenue growth in 2021.

The New Brunswick, N.J.-based pharmaceutical company said it now expects adjusted earnings of $9.60 to $9.70 a share this year. In April, it had forecast adjusted earnings of $9.42 to $9.57 a share.

The company said it now expects sales of $93.8 billion to $94.6 billion. In April, it had forecast sales of $90.6 billion to $91.6 billion.

The earnings and sales forecasts include estimates of J&J's Covid-19 vaccine operations.

Write to Matt Grossman at matt.grossman@wsj.com

(END) Dow Jones Newswires

07-21-21 0658ET